位置:首页 > 蛋白库 > WDR19_HUMAN
WDR19_HUMAN
ID   WDR19_HUMAN             Reviewed;        1342 AA.
AC   Q8NEZ3; B5MEF2; Q8N5B4; Q9H5S0; Q9HCD4;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 2.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=WD repeat-containing protein 19 {ECO:0000305};
DE   AltName: Full=Intraflagellar transport 144 homolog;
GN   Name=WDR19 {ECO:0000312|HGNC:HGNC:18340};
GN   Synonyms=IFT144 {ECO:0000303|PubMed:25860617, ECO:0000303|PubMed:27932497},
GN   KIAA1638;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RX   PubMed=12906858; DOI=10.1016/s0888-7543(03)00151-4;
RA   Lin B., White J.T., Utleg A.G., Wang S., Ferguson C., True L.D.,
RA   Vessella R., Hood L., Nelson P.S.;
RT   "Isolation and characterization of human and mouse WDR19,a novel WD-repeat
RT   protein exhibiting androgen-regulated expression in prostate epithelium.";
RL   Genomics 82:331-342(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 335-1239.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [7]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [8]
RP   FUNCTION, AND IDENTIFICATION IN THE IFT-A COMPLEX.
RX   PubMed=20889716; DOI=10.1101/gad.1966210;
RA   Mukhopadhyay S., Wen X., Chih B., Nelson C.D., Lane W.S., Scales S.J.,
RA   Jackson P.K.;
RT   "TULP3 bridges the IFT-A complex and membrane phosphoinositides to promote
RT   trafficking of G protein-coupled receptors into primary cilia.";
RL   Genes Dev. 24:2180-2193(2010).
RN   [9]
RP   FUNCTION, AND IDENTIFICATION IN THE IFT-A COMPLEX.
RX   PubMed=27932497; DOI=10.1091/mbc.e16-11-0813;
RA   Hirano T., Katoh Y., Nakayama K.;
RT   "Intraflagellar transport-A complex mediates ciliary entry and retrograde
RT   trafficking of ciliary G protein-coupled receptors.";
RL   Mol. Biol. Cell 28:429-439(2017).
RN   [10]
RP   IDENTIFICATION IN THE IFT-A COMPLEX.
RX   PubMed=29220510; DOI=10.1093/hmg/ddx421;
RA   Takahara M., Katoh Y., Nakamura K., Hirano T., Sugawa M., Tsurumi Y.,
RA   Nakayama K.;
RT   "Ciliopathy-associated mutations of IFT122 impair ciliary protein
RT   trafficking but not ciliogenesis.";
RL   Hum. Mol. Genet. 27:516-528(2018).
RN   [11]
RP   INVOLVEMENT IN SLSN8, AND VARIANTS SLSN8 PRO-30; ASP-68; GLU-109; CYS-272;
RP   HIS-493 AND SER-710.
RX   PubMed=23683095; DOI=10.1111/cge.12196;
RA   Coussa R.G., Otto E.A., Gee H.Y., Arthurs P., Ren H., Lopez I., Keser V.,
RA   Fu Q., Faingold R., Khan A., Schwartzentruber J., Majewski J.,
RA   Hildebrandt F., Koenekoop R.K.;
RT   "WDR19: an ancient, retrograde, intraflagellar ciliary protein is mutated
RT   in autosomal recessive retinitis pigmentosa and in Senior-Loken syndrome.";
RL   Clin. Genet. 84:150-159(2013).
RN   [12]
RP   INVOLVEMENT IN SLSN8, AND VARIANTS SLSN8 HIS-493; GLN-1178 AND LYS-1235.
RX   PubMed=23559409; DOI=10.1007/s00439-013-1297-0;
RA   Halbritter J., Porath J.D., Diaz K.A., Braun D.A., Kohl S., Chaki M.,
RA   Allen S.J., Soliman N.A., Hildebrandt F., Otto E.A.;
RT   "Identification of 99 novel mutations in a worldwide cohort of 1,056
RT   patients with a nephronophthisis-related ciliopathy.";
RL   Hum. Genet. 132:865-884(2013).
RN   [13]
RP   INTERACTION WITH TTC25.
RX   PubMed=25860617; DOI=10.1371/journal.pone.0124378;
RA   Xu Y., Cao J., Huang S., Feng D., Zhang W., Zhu X., Yan X.;
RT   "Characterization of tetratricopeptide repeat-containing proteins critical
RT   for cilia formation and function.";
RL   PLoS ONE 10:E0124378-E0124378(2015).
RN   [14]
RP   VARIANT SRTD5 PRO-7, VARIANT NPHP13 GLY-345, AND VARIANT CED4 SER-710.
RX   PubMed=22019273; DOI=10.1016/j.ajhg.2011.10.001;
RA   Bredrup C., Saunier S., Oud M.M., Fiskerstrand T., Hoischen A.,
RA   Brackman D., Leh S.M., Midtbo M., Filhol E., Bole-Feysot C., Nitschke P.,
RA   Gilissen C., Haugen O.H., Sanders J.S., Stolte-Dijkstra I., Mans D.A.,
RA   Steenbergen E.J., Hamel B.C., Matignon M., Pfundt R., Jeanpierre C.,
RA   Boman H., Rodahl E., Veltman J.A., Knappskog P.M., Knoers N.V., Roepman R.,
RA   Arts H.H.;
RT   "Ciliopathies with skeletal anomalies and renal insufficiency due to
RT   mutations in the IFT-A gene WDR19.";
RL   Am. J. Hum. Genet. 89:634-643(2011).
CC   -!- FUNCTION: As component of the IFT complex A (IFT-A), a complex required
CC       for retrograde ciliary transport and entry into cilia of G protein-
CC       coupled receptors (GPCRs), it is involved in cilia function and/or
CC       assembly (PubMed:20889716). Essential for functional IFT-A assembly and
CC       ciliary entry of GPCRs (PubMed:20889716). Associates with the BBSome
CC       complex to mediate ciliary transport (By similarity).
CC       {ECO:0000250|UniProtKB:Q3UGF1, ECO:0000269|PubMed:20889716}.
CC   -!- SUBUNIT: Component of the IFT complex A (IFT-A) complex
CC       (PubMed:20889716, PubMed:27932497). IFT-A complex is divided into a
CC       core subcomplex composed of IFT122:IFT140:WDR19 which is associated
CC       with TULP3 and a peripheral subcomplex composed of IFT43:WDR35:TTC21B
CC       (PubMed:27932497, PubMed:29220510). Interacts (via C-terminal region)
CC       with IFT122 (via C-terminal region) (PubMed:29220510). Interacts with
CC       BBS1 (By similarity). Interacts with TTC25 (PubMed:25860617).
CC       {ECO:0000250|UniProtKB:Q3UGF1, ECO:0000269|PubMed:20889716,
CC       ECO:0000269|PubMed:25860617, ECO:0000269|PubMed:27932497,
CC       ECO:0000269|PubMed:29220510}.
CC   -!- INTERACTION:
CC       Q8NEZ3; Q9HBG6: IFT122; NbExp=5; IntAct=EBI-11903679, EBI-2805994;
CC       Q8NEZ3; Q96RY7: IFT140; NbExp=8; IntAct=EBI-11903679, EBI-308494;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q3UGF1}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:Q3UGF1}. Cell projection, cilium,
CC       photoreceptor outer segment {ECO:0000250|UniProtKB:Q3UGF1}.
CC       Note=Localizes to photoreceptor connecting cilia, to the base of motile
CC       cilia in brain ependymal cells and to the base of and along primary
CC       cilia in kidney cells. {ECO:0000250|UniProtKB:Q3UGF1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NEZ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NEZ3-2; Sequence=VSP_018073, VSP_018074;
CC   -!- TISSUE SPECIFICITY: Some isoforms are tissue-specific. Highly expressed
CC       in the prostate. Lower expression in the cerebellum, pituitary gland,
CC       fetal lung, and pancreas. In normal prostate, expressed in both basal
CC       and luminal epithelial cells. No expression detected in fibromuscular
CC       stromal cells, endothelial cells, or infiltrating lymphocytes.
CC       Uniformed expression in prostate adenocarcinoma cells.
CC       {ECO:0000269|PubMed:12906858}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal lung.
CC   -!- INDUCTION: By androgenic hormones. Expression increased 3-fold in an
CC       androgen-stimulated androgen-sensitive prostate adenocarcinoma cell
CC       line compared with androgen-deprived cells.
CC       {ECO:0000269|PubMed:12906858}.
CC   -!- DISEASE: Cranioectodermal dysplasia 4 (CED4) [MIM:614378]: A disorder
CC       primarily characterized by craniofacial, skeletal and ectodermal
CC       abnormalities. Clinical features include craniosynostosis, narrow rib
CC       cage, short limbs, brachydactyly, hypoplastic and widely spaced teeth,
CC       sparse hair, skin laxity and abnormal nails. Nephronophthisis leading
CC       to progressive renal failure, hepatic fibrosis, heart defects, and
CC       retinitis pigmentosa have also been described.
CC       {ECO:0000269|PubMed:22019273}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Short-rib thoracic dysplasia 5 with or without polydactyly
CC       (SRTD5) [MIM:614376]: A form of short-rib thoracic dysplasia, a group
CC       of autosomal recessive ciliopathies that are characterized by a
CC       constricted thoracic cage, short ribs, shortened tubular bones, and a
CC       'trident' appearance of the acetabular roof. Polydactyly is variably
CC       present. Non-skeletal involvement can include cleft lip/palate as well
CC       as anomalies of major organs such as the brain, eye, heart, kidneys,
CC       liver, pancreas, intestines, and genitalia. Some forms of the disease
CC       are lethal in the neonatal period due to respiratory insufficiency
CC       secondary to a severely restricted thoracic cage, whereas others are
CC       compatible with life. Disease spectrum encompasses Ellis-van Creveld
CC       syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-
CC       Saldino syndrome, and short rib-polydactyly syndrome.
CC       {ECO:0000269|PubMed:22019273}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Nephronophthisis 13 (NPHP13) [MIM:614377]: An autosomal
CC       recessive disorder resulting in end-stage renal disease. It is a
CC       progressive tubulo-interstitial kidney disorder histologically
CC       characterized by modifications of the tubules with thickening of the
CC       basement membrane, interstitial fibrosis and, in the advanced stages,
CC       medullary cysts. {ECO:0000269|PubMed:22019273}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- DISEASE: Senior-Loken syndrome 8 (SLSN8) [MIM:616307]: A renal-retinal
CC       disorder characterized by progressive wasting of the filtering unit of
CC       the kidney (nephronophthisis), with or without medullary cystic renal
CC       disease, and progressive eye disease. Typically this disorder becomes
CC       apparent during the first year of life. {ECO:0000269|PubMed:23559409,
CC       ECO:0000269|PubMed:23683095}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH32578.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY029257; AAK38745.1; -; mRNA.
DR   EMBL; AK026780; BAB15550.1; -; mRNA.
DR   EMBL; AC093855; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW92921.1; -; Genomic_DNA.
DR   EMBL; BC032578; AAH32578.1; ALT_FRAME; mRNA.
DR   EMBL; AB046858; BAB13464.1; -; mRNA.
DR   CCDS; CCDS47042.1; -. [Q8NEZ3-1]
DR   RefSeq; NP_001304853.1; NM_001317924.1.
DR   RefSeq; NP_079408.3; NM_025132.3. [Q8NEZ3-1]
DR   AlphaFoldDB; Q8NEZ3; -.
DR   SMR; Q8NEZ3; -.
DR   BioGRID; 121748; 30.
DR   ComplexPortal; CPX-5021; IFT-A complex.
DR   CORUM; Q8NEZ3; -.
DR   IntAct; Q8NEZ3; 21.
DR   MINT; Q8NEZ3; -.
DR   STRING; 9606.ENSP00000382717; -.
DR   iPTMnet; Q8NEZ3; -.
DR   PhosphoSitePlus; Q8NEZ3; -.
DR   BioMuta; WDR19; -.
DR   DMDM; 94730676; -.
DR   EPD; Q8NEZ3; -.
DR   jPOST; Q8NEZ3; -.
DR   MassIVE; Q8NEZ3; -.
DR   MaxQB; Q8NEZ3; -.
DR   PaxDb; Q8NEZ3; -.
DR   PeptideAtlas; Q8NEZ3; -.
DR   PRIDE; Q8NEZ3; -.
DR   ProteomicsDB; 73250; -. [Q8NEZ3-1]
DR   ProteomicsDB; 73251; -. [Q8NEZ3-2]
DR   Antibodypedia; 23402; 126 antibodies from 20 providers.
DR   DNASU; 57728; -.
DR   Ensembl; ENST00000399820.8; ENSP00000382717.3; ENSG00000157796.18. [Q8NEZ3-1]
DR   GeneID; 57728; -.
DR   KEGG; hsa:57728; -.
DR   MANE-Select; ENST00000399820.8; ENSP00000382717.3; NM_025132.4; NP_079408.3.
DR   UCSC; uc003gtv.3; human. [Q8NEZ3-1]
DR   CTD; 57728; -.
DR   DisGeNET; 57728; -.
DR   GeneCards; WDR19; -.
DR   GeneReviews; WDR19; -.
DR   HGNC; HGNC:18340; WDR19.
DR   HPA; ENSG00000157796; Low tissue specificity.
DR   MalaCards; WDR19; -.
DR   MIM; 608151; gene.
DR   MIM; 614376; phenotype.
DR   MIM; 614377; phenotype.
DR   MIM; 614378; phenotype.
DR   MIM; 616307; phenotype.
DR   neXtProt; NX_Q8NEZ3; -.
DR   OpenTargets; ENSG00000157796; -.
DR   Orphanet; 1515; Cranioectodermal dysplasia.
DR   Orphanet; 474; Jeune syndrome.
DR   Orphanet; 93592; Juvenile nephronophthisis.
DR   Orphanet; 3156; Senior-Loken syndrome.
DR   PharmGKB; PA38317; -.
DR   VEuPathDB; HostDB:ENSG00000157796; -.
DR   eggNOG; KOG2247; Eukaryota.
DR   GeneTree; ENSGT00590000083165; -.
DR   HOGENOM; CLU_003002_2_0_1; -.
DR   InParanoid; Q8NEZ3; -.
DR   OMA; KNTIPFC; -.
DR   OrthoDB; 215211at2759; -.
DR   PhylomeDB; Q8NEZ3; -.
DR   TreeFam; TF314758; -.
DR   PathwayCommons; Q8NEZ3; -.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5620924; Intraflagellar transport.
DR   SignaLink; Q8NEZ3; -.
DR   BioGRID-ORCS; 57728; 13 hits in 1081 CRISPR screens.
DR   ChiTaRS; WDR19; human.
DR   GenomeRNAi; 57728; -.
DR   Pharos; Q8NEZ3; Tbio.
DR   PRO; PR:Q8NEZ3; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q8NEZ3; protein.
DR   Bgee; ENSG00000157796; Expressed in right uterine tube and 177 other tissues.
DR   ExpressionAtlas; Q8NEZ3; baseline and differential.
DR   Genevisible; Q8NEZ3; HS.
DR   GO; GO:0097542; C:ciliary tip; TAS:Reactome.
DR   GO; GO:0005929; C:cilium; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0030991; C:intraciliary transport particle A; IDA:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; ISS:UniProtKB.
DR   GO; GO:0097730; C:non-motile cilium; ISS:UniProtKB.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; ISS:UniProtKB.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:UniProtKB-SubCell.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0060830; P:ciliary receptor clustering involved in smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0055123; P:digestive system development; IEA:Ensembl.
DR   GO; GO:0042471; P:ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0008406; P:gonad development; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0035721; P:intraciliary retrograde transport; IMP:MGI.
DR   GO; GO:0061055; P:myotome development; IEA:Ensembl.
DR   GO; GO:0050877; P:nervous system process; IEA:Ensembl.
DR   GO; GO:1903441; P:protein localization to ciliary membrane; IMP:UniProtKB.
DR   GO; GO:0065003; P:protein-containing complex assembly; IMP:UniProtKB.
DR   GO; GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR040379; WDR19/dyf-2.
DR   InterPro; IPR039468; WDR19_WD40_rpt.
DR   PANTHER; PTHR14920; PTHR14920; 1.
DR   Pfam; PF15911; WD40_3; 1.
DR   SMART; SM00320; WD40; 5.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Ciliopathy; Cilium;
KW   Cilium biogenesis/degradation; Cytoplasm; Cytoskeleton; Disease variant;
KW   Ectodermal dysplasia; Leber congenital amaurosis; Nephronophthisis;
KW   Reference proteome; Repeat; Senior-Loken syndrome; TPR repeat; WD repeat.
FT   CHAIN           1..1342
FT                   /note="WD repeat-containing protein 19"
FT                   /id="PRO_0000233156"
FT   REPEAT          11..51
FT                   /note="WD 1"
FT   REPEAT          52..92
FT                   /note="WD 2"
FT   REPEAT          95..134
FT                   /note="WD 3"
FT   REPEAT          137..175
FT                   /note="WD 4"
FT   REPEAT          273..311
FT                   /note="WD 5"
FT   REPEAT          317..356
FT                   /note="WD 6"
FT   REPEAT          736..769
FT                   /note="TPR 1"
FT   REPEAT          775..808
FT                   /note="TPR 2"
FT   REPEAT          840..873
FT                   /note="TPR 3"
FT   REPEAT          895..928
FT                   /note="TPR 4"
FT   REPEAT          951..984
FT                   /note="TPR 5"
FT   REPEAT          1020..1053
FT                   /note="TPR 6"
FT   VAR_SEQ         453..474
FT                   /note="IESEILDAQEERETRLFPAVDD -> KAKSWMLTKNVRLGFSQQWMISAVSY
FT                   AMP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018073"
FT   VAR_SEQ         475..1342
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018074"
FT   VARIANT         7
FT                   /note="L -> P (in SRTD5; dbSNP:rs387906982)"
FT                   /evidence="ECO:0000269|PubMed:22019273"
FT                   /id="VAR_067312"
FT   VARIANT         30
FT                   /note="A -> P (in SLSN8; dbSNP:rs776967770)"
FT                   /evidence="ECO:0000269|PubMed:23683095"
FT                   /id="VAR_073673"
FT   VARIANT         68
FT                   /note="V -> D (in SLSN8; dbSNP:rs786204852)"
FT                   /evidence="ECO:0000269|PubMed:23683095"
FT                   /id="VAR_073674"
FT   VARIANT         109
FT                   /note="G -> E (in SLSN8; dbSNP:rs766029437)"
FT                   /evidence="ECO:0000269|PubMed:23683095"
FT                   /id="VAR_073675"
FT   VARIANT         272
FT                   /note="R -> C (in SLSN8; dbSNP:rs199812132)"
FT                   /evidence="ECO:0000269|PubMed:23683095"
FT                   /id="VAR_073676"
FT   VARIANT         345
FT                   /note="V -> G (in NPHP13; dbSNP:rs387906983)"
FT                   /evidence="ECO:0000269|PubMed:22019273"
FT                   /id="VAR_067313"
FT   VARIANT         493
FT                   /note="D -> H (in SLSN8; dbSNP:rs587777349)"
FT                   /evidence="ECO:0000269|PubMed:23559409,
FT                   ECO:0000269|PubMed:23683095"
FT                   /id="VAR_073677"
FT   VARIANT         710
FT                   /note="L -> S (in CED4 and SLSN8; dbSNP:rs387906980)"
FT                   /evidence="ECO:0000269|PubMed:22019273,
FT                   ECO:0000269|PubMed:23683095"
FT                   /id="VAR_067314"
FT   VARIANT         1084
FT                   /note="G -> S (in dbSNP:rs16995209)"
FT                   /id="VAR_053424"
FT   VARIANT         1178
FT                   /note="R -> Q (in SLSN8; dbSNP:rs79436363)"
FT                   /evidence="ECO:0000269|PubMed:23559409"
FT                   /id="VAR_073678"
FT   VARIANT         1235
FT                   /note="E -> K (in SLSN8; dbSNP:rs587777351)"
FT                   /evidence="ECO:0000269|PubMed:23559409"
FT                   /id="VAR_073679"
FT   CONFLICT        22
FT                   /note="Q -> K (in Ref. 1; AAK38745)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        122
FT                   /note="L -> V (in Ref. 2; BAB15550)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        153
FT                   /note="L -> P (in Ref. 2; BAB15550)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1342 AA;  151581 MW;  FF3DD302231CB5F6 CRC64;
     MKRIFSLLEK TWLGAPIQFA WQKTSGNYLA VTGADYIVKI FDRHGQKRSE INLPGNCVAM
     DWDKDGDVLA VIAEKSSCIY LWDANTNKTS QLDNGMRDQM SFLLWSKVGS FLAVGTVKGN
     LLIYNHQTSR KIPVLGKHTK RITCGCWNAE NLLALGGEDK MITVSNQEGD TIRQTQVRSE
     PSNMQFFLMK MDDRTSAAES MISVVLGKKT LFFLNLNEPD NPADLEFQQD FGNIVCYNWY
     GDGRIMIGFS CGHFVVISTH TGELGQEIFQ ARNHKDNLTS IAVSQTLNKV ATCGDNCIKI
     QDLVDLKDMY VILNLDEENK GLGTLSWTDD GQLLALSTQR GSLHVFLTKL PILGDACSTR
     IAYLTSLLEV TVANPVEGEL PITVSVDVEP NFVAVGLYHL AVGMNNRAWF YVLGENAVKK
     LKDMEYLGTV ASICLHSDYA AALFEGKVQL HLIESEILDA QEERETRLFP AVDDKCRILC
     HALTSDFLIY GTDTGVVQYF YIEDWQFVND YRHPVSVKKI FPDPNGTRLV FIDEKSDGFV
     YCPVNDATYE IPDFSPTIKG VLWENWPMDK GVFIAYDDDK VYTYVFHKDT IQGAKVILAG
     STKVPFAHKP LLLYNGELTC QTQSGKVNNI YLSTHGFLSN LKDTGPDELR PMLAQNLMLK
     RFSDAWEMCR ILNDEAAWNE LARACLHHME VEFAIRVYRR IGNVGIVMSL EQIKGIEDYN
     LLAGHLAMFT NDYNLAQDLY LASSCPIAAL EMRRDLQHWD SALQLAKHLA PDQIPFISKE
     YAIQLEFAGD YVNALAHYEK GITGDNKEHD EACLAGVAQM SIRMGDIRRG VNQALKHPSR
     VLKRDCGAIL ENMKQFSEAA QLYEKGLYYD KAASVYIRSK NWAKVGDLLP HVSSPKIHLQ
     YAKAKEADGR YKEAVVAYEN AKQWQSVIRI YLDHLNNPEK AVNIVRETQS LDGAKMVARF
     FLQLGDYGSA IQFLVMSKCN NEAFTLAQQH NKMEIYADII GSEDTTNEDY QSIALYFEGE
     KRYLQAGKFF LLCGQYSRAL KHFLKCPSSE DNVAIEMAIE TVGQAKDELL TNQLIDHLLG
     ENDGMPKDAK YLFRLYMALK QYREAAQTAI IIAREEQSAG NYRNAHDVLF SMYAELKSQK
     IKIPSEMATN LMILHSYILV KIHVKNGDHM KGARMLIRVA NNISKFPSHI VPILTSTVIE
     CHRAGLKNSA FSFAAMLMRP EYRSKIDAKY KKKIEGMVRR PDISEIEEAT TPCPFCKFLL
     PECELLCPGC KNSIPYCIAT GRHMLKDDWT VCPHCDFPAL YSELKIMLNT ESTCPMCSER
     LNAAQLKKIS DCTQYLRTEE EL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024